|
Volumn 368, Issue 16, 2013, Pages 1557-1558
|
Drug-eluting coronary-artery stents
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
CLOPIDOGREL;
PROTON PUMP INHIBITOR;
PURINERGIC P2Y RECEPTOR ANTAGONIST;
WARFARIN;
BARE METAL STENT;
BLEEDING;
BLEEDING TENDENCY;
CLINICAL TRIAL (TOPIC);
CORONARY STENT;
DRUG ELUTING STENT;
GASTROINTESTINAL DISEASE;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
LETTER;
LOW DRUG DOSE;
METAL IMPLANTATION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK REDUCTION;
STOMACH PROTECTION;
THROMBOSIS;
THROMBOSIS PREVENTION;
|
EID: 84876320873
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1301999 Document Type: Letter |
Times cited : (3)
|
References (5)
|